We also measured the hepatic expression values of a panel of genes involved in NAFLD progression (FASN, SREBP1, PPARα, PPARγ, CPT1, Col1A1) in all patients (n=33). Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.